Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Digital Health
Hims & Hers bumps up 2024 revenue forecast to $1.2B
Hims & Hers raised full-year 2024 guidance to a range of $1.2 billion to $1.23 billion.
Heather Landi
May 7, 2024 5:00pm
Clover Health authorizes $20 million share buyback program
May 7, 2024 4:45pm
Oscar Health records first quarterly net profit
May 7, 2024 8:45am
Amwell bullish on future growth despite Q1 revenue decline
May 6, 2024 2:00pm
A look at how major payers performed in the first quarter
May 3, 2024 4:45pm
Alignment raises membership guidance but posts $47M net loss
May 2, 2024 4:09pm